These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11686071)

  • 1. Mechanical and pharmacologic treatment of vasospasm.
    American Society of Interventional and Therapeutic Neuroradiology
    AJNR Am J Neuroradiol; 2001 Sep; 22(8 Suppl):S26-7. PubMed ID: 11686071
    [No Abstract]   [Full Text] [Related]  

  • 2. Endovascular treatment of cerebral vasospasm.
    Smith TP; Enterline DS
    J Vasc Interv Radiol; 2000 May; 11(5):547-59. PubMed ID: 10834484
    [No Abstract]   [Full Text] [Related]  

  • 3. Current indications and results of cerebral angioplasty.
    Newell DW; Eskridge JM; Aaslid R
    Acta Neurochir Suppl; 2001; 77():181-3. PubMed ID: 11563282
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of outcome after endovascular treatment of cerebral vasospasm.
    Rabinstein AA; Friedman JA; Nichols DA; Pichelmann MA; McClelland RL; Manno EM; Atkinson JL; Wijdicks EF
    AJNR Am J Neuroradiol; 2004; 25(10):1778-82. PubMed ID: 15569745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intra-arterial infusion of papaverine hydrochloride on brain tissue oxygen pressure in the management of severe vasospasm following aneurysmal subarachnoid hemorrhage.
    Reisch R; Filippi R; Böcher-Schwarz H; Mauer D; Ringel K; Stoeter P; Perneczky A
    Acta Neurochir Suppl; 2001; 77():191-3. PubMed ID: 11563284
    [No Abstract]   [Full Text] [Related]  

  • 6. Papaverine and vasospasm.
    Tsurushima H; Hyodo A; Yoshii Y
    J Neurosurg; 2000 Mar; 92(3):509-11. PubMed ID: 10701553
    [No Abstract]   [Full Text] [Related]  

  • 7. Endovascular treatment strategies for cerebral vasospasm.
    Mindea SA; Yang BP; Bendok BR; Miller JW; Batjer HH
    Neurosurg Focus; 2006 Sep; 21(3):E13. PubMed ID: 17029337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on endovascular therapies for cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.
    Sayama CM; Liu JK; Couldwell WT
    Neurosurg Focus; 2006 Sep; 21(3):E12. PubMed ID: 17029336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment of cerebral vasospasm following S.A.H.
    Barreau X; Pastore M; Piotin M; Spelle C; Moret J
    Acta Neurochir Suppl; 2001; 77():177-80. PubMed ID: 11563281
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage.
    Liu JK; Couldwell WT
    Neurocrit Care; 2005; 2(2):124-32. PubMed ID: 16159054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular therapy for vasospasm.
    Srinivasan J; Eskridge J; Grady MS; Newell DW; Winn HR
    Clin Neurosurg; 2002; 49():261-73. PubMed ID: 12506559
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms.
    Elsayed AA; Moran CJ; Cross DT; Derdeyn CP; Pilgram TK; Milburn JM; Dacey RG; Diringer MN
    Neurosurg Focus; 2006 Sep; 21(3):E16. PubMed ID: 17029340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient oculomotor nerve palsy after topical administration of intracisternal papaverine.
    Chittiboina P; Willet O; Nanda A; Guthikonda B
    Acta Neurochir (Wien); 2011 Feb; 153(2):431-3. PubMed ID: 21076927
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm.
    Liu JK; Tenner MS; Gottfried ON; Stevens EA; Rosenow JM; Madan N; MacDonald JD; Kestle JR; Couldwell WT
    J Neurosurg; 2004 Mar; 100(3):414-21. PubMed ID: 15035276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined endovascular therapy of ruptured aneurysms and cerebral vasospasm.
    Wanke I; Dörfler A; Dietrich U; Aalders T; Forsting M
    Neuroradiology; 2000 Dec; 42(12):926-9. PubMed ID: 11198215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endovascular treatment for cerebral vasospasm].
    Ezura M; Takahashi A
    No To Shinkei; 2000 Jun; 52(6):488-94. PubMed ID: 10875119
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage].
    Alcázar PP; González A; Romance A
    Med Intensiva; 2008 Nov; 32(8):391-7. PubMed ID: 19055932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Smith WS; Dowd CF; Johnston SC; Ko NU; DeArmond SJ; Dillon WP; Setty D; Lawton MT; Young WL; Higashida RT; Halbach VV
    Stroke; 2004 Nov; 35(11):2518-22. PubMed ID: 15472097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen.
    Stiefel MF; Spiotta AM; Udoetuk JD; Maloney-Wilensky E; Weigele JB; Hurst RW; LeRoux PD
    Neurocrit Care; 2006; 4(2):113-8. PubMed ID: 16627898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
    Anand S; Goel G; Gupta V
    J Neurosurg Anesthesiol; 2014 Jan; 26(1):92-3. PubMed ID: 23774116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.